                         SEQUENCE LISTING

<110>  THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
       Butte, Manish
 
<120>  PROTEIN PRODUCING NANOLIPOSOMES AND USES THEREOF

<130>  P-590050-PC

<140>  PCT/US20/51365
<141>  2020-09-18

<150>  US 62/902,390
<151>  2019-09-18

<150>  US 62/902,883
<151>  2019-09-19

<160>  10    

<170>  PatentIn version 3.5

<210>  1
<211>  40
<212>  DNA
<213>  Artificial

<220>
<223>  H9 IL-2 Superkine FWD

<400>  1
ttattttatt ttatttaacc ggagccatgg gagaattcgc                             40


<210>  2
<211>  43
<212>  DNA
<213>  Artificial

<220>
<223>  H9 IL-2 Superkine REV

<400>  2
ggaggagggc ggccgcttac ctaagttagt gttgagatga tgc                         43


<210>  3
<211>  40
<212>  DNA
<213>  Artificial

<220>
<223>  pCellFree_G03_IL2 backbone, first section FWD

<400>  3
gcgaattctc ccatggctcc ggttaaataa aataaaataa                             40


<210>  4
<211>  40
<212>  DNA
<213>  Artificial

<220>
<223>  pCellFree_G03_IL2 backbone, first section REV

<400>  4
ttgctacagg catcgtggtg tcacgctcgt cgtttggtat                             40


<210>  5
<211>  40
<212>  DNA
<213>  Artificial

<220>
<223>  pCellFree_G03_IL2 backbone, second section FWD

<400>  5
ataccaaacg acgagcgtga caccacgatg cctgtagcaa                             40


<210>  6
<211>  43
<212>  DNA
<213>  Artificial

<220>
<223>  pCellFree_G03_IL2 backbone, second section REV

<400>  6
gcatcatctc aacactaact taggtaagcg gccgccctcc tcc                         43


<210>  7
<211>  420
<212>  DNA
<213>  Artificial

<220>
<223>  IL-2 of Superkine (Super2)

<400>  7
ggagccatgg gagaattcgc acctacttca agttctacaa agaaaacaca gctacaactg       60

gagcatttac ttctggattt acagatgatt ttgaatggaa ttaataatta caagaatccc      120

aaactcacca ggatgctcac atttaagttt tacatgccca agaaggccac agaactgaaa      180

catcttcagt gtctagaaga agaactcaaa cctctggagg aagtgctaaa tttagctcag      240

agcaaaaact ttcacttcga tcccagggac gtcgtcagca atatcaacgt attcgtcctg      300

gaactaaagg gatctgaaac aacattcatg tgtgaatatg ctgatgagac agcaaccatt      360

gtagaatttc tgaacagatg gattaccttt tgtcaaagca tcatctcaac actaactcat      420


<210>  8
<211>  8
<212>  PRT
<213>  Artificial

<220>
<223>  RGD containing peptide

<400>  8

Gly Gly Gly Gly Arg Gly Asp Tyr 
1               5               


<210>  9
<211>  2115
<212>  DNA
<213>  Artificial

<220>
<223>  Plasmid with IL-2 Superkine (Super2)

<400>  9
gaaattgtta tccgctcaca attccacaca acatacgagc cggaagcata aagtgtaaag       60

cctggggtgc ctaatgagtg agctaactca cattaattgc gttgcgctca ctgcccgctt      120

tccagtcggg aaacctgtcg tgccagctgc attaatgaat cggccaacgc gcggggagag      180

gcggtttgcg tattgggcgc tcttccgctt cctcgctcac tgactcgctg cgctcggtcg      240

ttcggctgcg gcgagcggta tcagctcact caaaggcggt aatacggtta tccacagaat      300

caggggataa cgcaggaaag aacatgtgag caaaaggcca gcaaaaggcc aggaaccgta      360

aaaaggccgc gttgctggcg tttttccata ggctccgccc ccctgacgag catcacaaaa      420

atcgacgctc aagtcagagg tggcgaaacc cgacaggact ataaagatac caggcgtttc      480

cccctggaag ctccctcgtg cgctctcctg ttccgaccct gccgcttacc ggatacctgt      540

ccgcctttct cccttcggga agcgtggcgc tttctcatag ctcacgctgt aggtatctca      600

gttcggtgta ggtcgttcgc tccaagctgg gctgtgtgca cgaacccccc gttcagcccg      660

accgctgcgc cttatccggt aactatcgtc ttgagtccaa cccggtaaga cacgacttat      720

cgccactggc agcagccact ggtaacagga ttagcagagc gaggtatgta ggcggtgcta      780

cagagttctt gaagtggtgg cctaactacg gctacactag aagaacagta tttggtatct      840

gcgctctgct gaagccagtt accttcggaa aaagagttgg tagctcttga tccggcaaac      900

aaaccaccgc tggtagcggt ggtttttttg tttgcaagca gcagattacg cgcagaaaaa      960

aaggatctca agaggatcct ttgatctttt ctacggggtc tgacgctcag tggaacgaaa     1020

actcacgtta agggattttg gtcatgagat tatcaaaaag gatcttcacc tagatccttt     1080

taaattaaaa atgaagtttt aaatcaatct aaagtatata tgagtaaact tggtctgaca     1140

gttaccaatg cttaatcagt gaggcaccta tctcagcgat ctgtctagtt cgttcatcca     1200

tagttgcctg actccccgtc gtgtagataa ctacgatacg ggagggctta ccatctggcc     1260

ccagtgctgc aatgataccg cgagacccac gctcaccggc tccagattta tcagcaataa     1320

accagccagc cggaagggcc gagcgcagaa gtggtcctgc aactttatcc gcctccatcc     1380

agtctattaa ttgttgccgg gaagctagag taagtagttc gccagttaat agtttgcgca     1440

acgttgttgc cattgctaca ggcatcgtgg tgtcacgctc gtcgtttggt atggcttcat     1500

tcagctccgg ttcccaacga tcaaggcgag ttacatgatc ccccatgttg tgcaaaaaag     1560

cggttagctc cttcggtcct ccgatcgttg tcagaagtaa gttggccgca gtgttatcac     1620

tcatggttat ggcagcactg cataattctc ttactgtcat gccatccgta agatgctttt     1680

ctgtgactgg tgagtactca accaagtcat tctgagaata gtgtatgcgg cgaccgagtt     1740

gctcttgccc ggcgtcaata cgggataata ccgcgccaca tagcagaact ttaaaagtgc     1800

tcatcattgg aaaacgttct tcggggcgaa aactctcaag gatcttaccg ctgttgagat     1860

ccagttcgat gtaacccact cgtgcaccca actgatcttc agcatctttt actttcacca     1920

gcgtttctgg gtgagcaaaa acaggaaggc aaaatgccgc aaaaaaggga ataagggcga     1980

cacggaaatg ttgaatactc atactcttcc tttttcaata ttattgaagc atttatcagg     2040

gttattgtct catgagcgga tacatatttg aatgtattta gaaaaataaa caaatagggg     2100

ttccgcgcac atttc                                                      2115


<210>  10
<211>  138
<212>  PRT
<213>  Artificial

<220>
<223>  IL-2 Superkine (Super2)

<400>  10

Met Gly Glu Phe Ala Pro Thr Ser Ser Ser Thr Lys Lys Thr Gln Leu 
1               5                   10                  15      


Gln Leu Glu His Leu Leu Leu Asp Leu Gln Met Ile Leu Asn Gly Ile 
            20                  25                  30          


Asn Asn Tyr Lys Asn Pro Lys Leu Thr Arg Met Leu Thr Phe Lys Phe 
        35                  40                  45              


Tyr Met Pro Lys Lys Ala Thr Glu Leu Lys His Leu Gln Cys Leu Glu 
    50                  55                  60                  


Glu Glu Leu Lys Pro Leu Glu Glu Val Leu Asn Leu Ala Gln Ser Lys 
65                  70                  75                  80  


Asn Phe His Phe Asp Pro Arg Asp Val Val Ser Asn Ile Asn Val Phe 
                85                  90                  95      


Val Leu Glu Leu Lys Gly Ser Glu Thr Thr Phe Met Cys Glu Tyr Ala 
            100                 105                 110         


Asp Glu Thr Ala Thr Ile Val Glu Phe Leu Asn Arg Trp Ile Thr Phe 
        115                 120                 125             


Cys Gln Ser Ile Ile Ser Thr Leu Thr His 
    130                 135             


